Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study.

Jacqueline BoschMartin O'DonnellBalakumar SwaminathanEva Marie LonnMikul SharmaGilles DagenaisRafael DiazKamlesh KhuntiBasil S LewisAlvaro AvezumClaes HeldMatyas KeltaiChristopher ReidWilliam D ToffAntonio DansLawrence A LeiterKaren SliwaShun Fu LeeJanice M PogueRobert HartSalim Yusufnull null

Published in: Neurology (2019)

This study provides Class II evidence that for older people, candesartan plus hydrochlorothiazide, rosuvastatin, or their combination does not significantly affect cognitive decline.

Keyphrases

cognitive decline
blood pressure
mild cognitive impairment
type diabetes
fatty acid
hypertensive patients